Eva Tomiak

5.3k total citations
59 papers, 1.6k citations indexed

About

Eva Tomiak is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Eva Tomiak has authored 59 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 13 papers in Genetics. Recurrent topics in Eva Tomiak's work include Cancer Treatment and Pharmacology (16 papers), BRCA gene mutations in cancer (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Eva Tomiak is often cited by papers focused on Cancer Treatment and Pharmacology (16 papers), BRCA gene mutations in cancer (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Eva Tomiak collaborates with scholars based in Canada, Belgium and Netherlands. Eva Tomiak's co-authors include Barbara Collins, Angela Stewart, Catherine Bielajew, William K. Evans, Martine Piccart, S. Verma, B P Will, Christel Le Petit, Shailendra Verma and David J. Stewart and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Eva Tomiak

57 papers receiving 1.6k citations

Peers

Countries citing papers authored by Eva Tomiak

Since Specialization

Citations

This map shows the geographic impact of Eva Tomiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Tomiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Tomiak more than expected).

Fields of papers citing papers by Eva Tomiak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Tomiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Tomiak. The network helps show where Eva Tomiak may publish in the future.

Co-authorship network of co-authors of Eva Tomiak

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Tomiak. A scholar is included among the top collaborators of Eva Tomiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Tomiak. Eva Tomiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Canadian Urological Association Best Practice Report on the long-term followup for patients with pheochromocytomas 2019 ·Canadian Urological Association Journal ·(unknown), Philippe D. Violette, Christopher Tran, Eva Tomiak, Jason Izard, (unknown), (unknown)	3
2	Using Family History Forms in Pediatric Oncology to Identify Patients for Genetic Assessment 2017 ·Current Oncology ·(unknown), (unknown), Jacques Hamon, Eva Tomiak, Mylène Bassal, Sarah L. Sawyer	3
3	Recurrent spontaneous pneumothoraces and bullous emphysema. A novel mutation causing Birt-Hogg-Dube syndrome 2016 ·Respiratory Medicine Case Reports ·(unknown), (unknown), Eva Tomiak, Nha Voduc	2
4	Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada 2014 ·Hereditary Cancer in Clinical Practice ·Taila Hartley, Luca Cavallone, Nelly Sabbaghian, Rachel Silva‐Smith, Nancy Hamel, Olga Aleynikova, (unknown), (unknown), Pedro Pinto, Marc Tischkowitz, Eva Tomiak, William D. Foulkes	18
5	Living with the BRCA1 and BRCA2 genetic mutation: Learning how to adapt to a virtual chronic illness 2013 ·Psychology Health & Medicine ·André Samson, (unknown), Anne Thériault, (unknown), (unknown), S. Verma, Eva Tomiak	15
6	Living with the BRCA genetic mutation: An uncertain conclusion to an unending process 2012 ·Psychology Health & Medicine ·(unknown), André Samson, Anne Thériault, (unknown), (unknown), S. Verma, Eva Tomiak	31
7	The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study 2007 ·Psycho-Oncology ·Angela Stewart, Barbara Collins, Joyce MacKenzie, Eva Tomiak, Shailendra Verma, Catherine Bielajew	131
8	Chemotherapy dose–response relationships in non-small cell lung cancer and implied resistance mechanisms 2007 ·Cancer Treatment Reviews ·David J. Stewart, (unknown), Simone Dahrouge, Srabani Banerjee, Eva Tomiak	35
9	A Meta-Analysis of the Neuropsychological Effects of Adjuvant Chemotherapy Treatment in Women Treated for Breast Cancer 2006 ·The Clinical Neuropsychologist ·Angela Stewart, Catherine Bielajew, Barbara Collins, (unknown), Eva Tomiak	174
10	Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115 2006 ·Annals of Oncology ·J. Maroun, K. Bélanger, Lesley Seymour, S. Matthews, James Roach, (unknown), Denis Soulières, David J. Stewart, Rakesh Goel, Danielle Charpentier, Glenwood Goss, Eva Tomiak, J. Yau, José Jimeno, (unknown)	51
11	A Phase III Study of High-Dose Intensification Without Hematopoietic Progenitor Cells Support for Patients With High-Risk Primary Breast Carcinoma 2000 ·American Journal of Clinical Oncology ·Jonathan C. Yau, (unknown), John Hanson, Shailendra Verma, L. Grimard, (unknown), I. Aref, P. Cross, Eva Tomiak, David J. Stewart, Diane Cyr, S. Huan	4
12	Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs 1999 ·British Journal of Cancer ·B P Will, Christel Le Petit, (unknown), Eva Tomiak, S. Verma, William K. Evans	29
13	A rapid reversed phase high performance liquid chromatographic method for the determination of docetaxel (Taxotere®) in human plasma using a column switching technique 1998 ·Journal of Pharmaceutical and Biomedical Analysis ·Mohammad Reza Rouini, (unknown), David J. Stewart, J. Matshela Molepo, Farshad H. Shirazi, J. Vergniol, Eva Tomiak, Fabian Delorme, Laurent Vernillet, (unknown), Rakesh Goel	41
14	Vorozole (Rivizor???): an active and well tolerated new aromatase inhibitor for the treatment of advanced breast cancer patients with prior tamoxifen exposure 1998 ·Anti-Cancer Drugs ·R. Paridaens, (unknown), M. Nooij, Jan G.M. Klijn, Stephen Houston, L.V.A.M. Beex, (unknown), Eva Tomiak, A. Van Vreckem, Christine Langenaeken, M. van Glabbeke, Martine Piccart	4
15	PP20. Opportunities to reduce the cost of care for breast cancer (BC) in Canada 1997 ·European Journal of Cancer ·W.K. Evans, (unknown), B P Will, J.M. Berthelot, Eva Tomiak, S. Verma	1
16	Pilot study of multiple chemotherapy resistance modulators plus epirubicin in the treatment of resistant malignancies 1997 ·Cancer Chemotherapy and Pharmacology ·(unknown), M. Christine Cripps, Rakesh Goel, Simone Dahrouge, (unknown), Eva Tomiak, S. Huan, (unknown), (unknown), Ross A. Davies	4
17	Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis. 1994 ·Journal of Clinical Oncology ·Eva Tomiak, Martine Piccart, Joseph Kerger, S. H. Lips, Ahmad Awada, Dominique de Valeriola, Christophe Ravoet, Dominique Lossignol, Jean‐Paul Sculier, (unknown)	125
18	The role of chemotherapy in invasive thymoma: a review of the literature and considerations for future clinical trials 1993 ·Critical Reviews in Oncology/Hematology ·Eva Tomiak, William K. Evans	21
19	Routine Follow-Up of Patients Following Primary Therapy for Early Breast Cancer: 1993 ·Acta Clinica Belgica ·Eva Tomiak, Martine Piccart	1
20	A phase I study of Taxotere (RP 56976 NSC 628503) administered as a one hour intravenous infusion on a weekly basis 1991 ·European Journal of Cancer ·Eva Tomiak, Martine Piccart, Joseph Kerger, Dominique de Valeriola, Elias Tueni, Dominique Lossignol, S. H. Lips, N Le Bail, M. Bayssas	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact